Announce Date | 04/22/2025 |
EPS Normalized Actual | $3.68 (Beat by $0.51) |
EPS GAAP Actual | $3.68 (Beat by $0.51) |
Revenue Actual | $13.353B |
Revenue Surprise | Beat by $13353M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $5.89904 |
EPS GAAP Estimate | $5.89904 |
Revenue Estimate | $13.8191639B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 27.54528 | 10.3 | 26.21392 | 28.29532 | 1 |
Dec 2026 | 24.55987 | 11.56 | 22.59 | 26.23885 | 5 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 3.32 | 3.32 | 13.353B | 3.44% | 13353M |
FQ4 2024 (Dec 2024) | 6.37 | 6.37 | 14.278B | 7.13% | 14278M |
FQ3 2024 (Sep 2024) | 5.75 | 5.75 | 14.872B | 6.72% | 14872M |
FQ2 2024 (Jun 2024) | 5.46 | 5.46 | 13.846B | 14.45% | 13846M |
FQ1 2024 (Mar 2024) | 5.29 | 5.29 | 12.894B | 13.16% | 12894M |
FQ4 2023 (Dec 2023) | 8.04 | 8.04 | 13.26B | 13.27% | 13260M |
FQ3 2023 (Sep 2023) | 5 | 5 | 13.872B | 12.56% | 13872M |
FQ2 2023 (Jun 2023) | 4.37 | 4.37 | 11.845B | 16.07% | 11845M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
5.89904
Consensus Revenue Estimates
13.8191639B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 7.6278 | -- | 7.46888 | 7.76105 | 4 |
FQ3 2027 (Sep 2027) | 5.62638 | -- | 5.50916 | 5.72467 | 7 |
FQ2 2027 (Jun 2027) | 6.68647 | -- | 6.54717 | 6.80328 | 4 |
FQ1 2027 (Mar 2027) | 7.0294 | -- | 6.88295 | 7.1522 | 4 |
FQ4 2026 (Oct 2026) | 5.66713 | -- | 5.41331 | 5.80422 | 7 |
FQ3 2026 (Jul 2026) | 6.3498 | -- | 6.06541 | 6.50341 | 12 |
FQ2 2026 (Jun 2026) | 6.3507 | -- | 6.0787 | 6.51169 | 11 |
FQ1 2026 (Mar 2026) | 6.14 | 45.93 | 5.87702 | 6.29565 | 6 |
FQ4 2025 (Oct 2025) | 5.41339 | -17.67 | 5.17094 | 5.54434 | 8 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 13.87B | -- | 13.65B | 14.06B | 3 |
FQ3 2027 (Sep 2027) | 16.33B | -- | 16.07B | 16.55B | 3 |
FQ2 2027 (Jun 2027) | 15.63B | -- | 15.38B | 15.84B | 3 |
FQ1 2027 (Mar 2027) | 14.04B | -- | 13.82B | 14.23B | 3 |
FQ4 2026 (Oct 2026) | 15.38B | -- | 14.85B | 15.66B | 4 |
FQ3 2026 (Jul 2026) | 14.48B | -- | 13.98B | 14.75B | 4 |
FQ2 2026 (Jun 2026) | 14.28B | -- | 13.8B | 14.55B | 4 |
FQ1 2026 (Mar 2026) | 12.83B | -4.08 | 12.41B | 13.08B | 4 |
FQ4 2025 (Oct 2025) | 14.82B | 3.66 | 14.31B | 15.1B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 3.32 | 3.32 | 100% | |
FQ4 2024 (Dec 2024) | 6.37 | 6.37 | 100% | |
FQ3 2024 (Sep 2024) | 5.75 | 5.75 | 100% | |
FQ2 2024 (Jun 2024) | 5.46 | 5.46 | 100% | |
FQ1 2024 (Mar 2024) | 5.29 | 5.29 | 100% | |
FQ4 2023 (Dec 2023) | 8.04 | 8.04 | 100% | |
FQ3 2023 (Sep 2023) | 5 | 5 | 100% | |
FQ2 2023 (Jun 2023) | 4.37 | 4.37 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $13.35B | $13353M | 100% |
FQ4 2024 (Dec 2024) | $0B | $14.28B | $14278M | 100% |
FQ3 2024 (Sep 2024) | $0B | $14.87B | $14872M | 100% |
FQ2 2024 (Jun 2024) | $0B | $13.85B | $13846M | 100% |
FQ1 2024 (Mar 2024) | $0B | $12.89B | $12894M | 100% |
FQ4 2023 (Dec 2023) | $0B | $13.26B | $13260M | 100% |
FQ3 2023 (Sep 2023) | $0B | $13.87B | $13872M | 100% |
FQ2 2023 (Jun 2023) | $0B | $11.85B | $11845M | 100% |